Navigation Links
Surgical breast biopsy not overused, study suggests
Date:1/31/2012

Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a study in the February issue of the Journal of the American College of Radiology. Surgical breast biopsies are more invasive than needle biopsies, requiring an incision and the use of general anesthesia.

Results from a previous study in 2011 in a surgical journal suggested that surgery is used for 30 percent of breast biopsies, an excessive number. However, in response, the authors of this JACR article thought that the reported results may overstate the percentage of biopsies performed as surgical biopsies. As a result, they sought to more accurately assess the use of needle biopsy compared with surgical biopsy.

The nationwide Medicare Part B databases for 2004 to 2009 were used during the study. Trends in use of codes for five different types of breast biopsies, including needle biopsy with imaging, needle biopsy without imaging and surgical biopsy were determined.

Using a more appropriate analysis of the biopsy codes, Medicare data indicated that the true surgical breast biopsy figure is somewhere between two percent and 18 percent, and probably close to eleven percent.

"In the Medicare population nationwide, it seems the use of surgical biopsy is substantially less than the 30 percent previously alleged," said David C. Levin, MD, lead author of the study.

"Given that the recommended rate is ten percent, it seems that surgeons and radiologists are collaborating well and that surgical breast biopsy is not being overused," said Levin.


'/>"/>
Contact: Heather Curry
PR@acr.org
703-390-9822
American College of Radiology
Source:Eurekalert

Page: 1

Related medicine news :

1. Regional surgical quality collaborative significantly improves surgical outcomes and reduces cost
2. Surgical robots to provide open-source platform for medical robotics research
3. University of Maryland Department of surgery continues to lead through surgical innovation
4. Older Women Have More Post-Surgical Breast Reduction Infections
5. Slower Walking Speed Linked to Surgical Risk in Elderly
6. Surgical treatment within six months of lumbar disc herniation
7. New aggression tool predicted violent patients in medical and surgical wards
8. Interfacility helicopter ambulance transport of neurosurgical patients
9. Anemia Could Add to Surgical Risks
10. Urgent assessment in emergency departments can reduce surgical decision time and overcrowding
11. Fewer Surgical Errors Reported at VA Medical Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology: